UNAIDS welcomes first WHO Covid Technology Access Pool licensing agreement
UNAIDS welcomes the first licensing agreement under the World Health Organization (WHO) COVID-19 Technology Access Pool (C-TAP) initiative, negotiated
Stay updated with breaking news from Technology Access Pool. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UNAIDS welcomes the first licensing agreement under the World Health Organization (WHO) COVID-19 Technology Access Pool (C-TAP) initiative, negotiated
UNAIDS welcomes the first licensing agreement under the World Health Organization (WHO) COVID-19 Technology Access Pool (C-TAP) initiative, negotiated between Consejo Superior de Investigaciones Científicas (Spain’s High Council of Scientific Research) and the Medicines Patent Pool.
A global licence for serological technology that detects COVID-19 antibodies will be provided royalty-free to poor and middle-income countries under a first of its kind agreement to boost production, the World Health Organisation said on Tuesday.
GENEVA: Spain’s top research institution reached a licensing deal Tuesday that paves the way for its Covid-19 antibody test to be produced more cheaply in developing countries. The World Health Organization (WHO) described the accord as the first transparent, global, non-exclusive license for a Covid-19 health tool that will help correct “devastating global inequity.” The deal
GENEVA (Reuters) - A global licence for serological technology that detects COVID-19 antibodies will be provided royalty-free to poor and middle-incom...